{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:00:54Z","timestamp":1787979654478,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10067-017-3776-5","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T13:12:39Z","timestamp":1501074759000},"page":"1295-1303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients"],"prefix":"10.1007","volume":"37","author":[{"given":"Jingran","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,26]]},"reference":[{"issue":"2","key":"3776_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295\u2013306. doi:\n10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"issue":"1","key":"3776_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.hoc.2007.10.007","volume":"22","author":"WF Baker Jr","year":"2008","unstructured":"Baker WF Jr, Bick RL (2008) Clinical spectrum of antiphospholipid syndrome. Hematol Oncol Clin North Am 22(1):33\u201352, v-vi. doi:\n10.1016\/j.hoc.2007.10.007","journal-title":"Hematol Oncol Clin North Am"},{"issue":"10","key":"3776_CR3","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/17474086.2016.1235969","volume":"9","author":"PL Meroni","year":"2016","unstructured":"Meroni PL, Argolini LM, Pontikaki I (2016) What is known about pediatric antiphospholipid syndrome? Expert Rev Hematol 9(10):977\u2013985. doi:\n10.1080\/17474086.2016.1235969","journal-title":"Expert Rev Hematol"},{"issue":"7","key":"3776_CR4","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"WA Wilson","year":"1999","unstructured":"Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42(7):1309\u20131311. doi:\n10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","journal-title":"Arthritis Rheum"},{"issue":"4","key":"3776_CR5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Qu\u00e9r\u00e9 I, Hachulla E, Vasconcelos C, Roch B, Fern\u00e1ndez-Nebro A, Boffa MC, Hughes GR, Ingelmo M, Euro-Phospholipid Project Group (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46(4):1019\u20131027 PMID: 11953980","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3776_CR6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0049-0172(99)80029-8","volume":"29","author":"FJ Mu\u00f1oz-Rodriguez","year":"1999","unstructured":"Mu\u00f1oz-Rodriguez FJ, Font J, Cervera R, Reverter JC, T\u00e0ssies D, Espinosa G, L\u00f3pez-Soto A, Carmona F, Balasch J, Ordinas A, Ingelmo M (1999) Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum 29(3):182\u2013190 PMID: 10622682","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"3776_CR7","first-page":"324","volume":"11","author":"QIAN Jie","year":"2007","unstructured":"Jie QIAN, Xiao-xiang CHEN, Shu-jie LI, Mei-fang WU, Ting ZENG, Yu-qiong ZOU, Yue-ying GU, Yuan WANG, Chun-de BAO, Shun-le CHEN, Cheng-de YANG (2007) Clinical characteristics of 115 Chinese patients with antiphospholipid syndrome and the analysis of different classification criteria. Chin J Rheumatol 11(6):324\u2013327","journal-title":"Chin J Rheumatol"},{"issue":"6","key":"3776_CR8","first-page":"394","volume":"14","author":"C Xiao-wei","year":"2010","unstructured":"Xiao-wei C, Yan S, Chuan-yin S, Cheng-de Y (2010) Clinical characteristics of 174 Chinese patients with antiphospholipid syndrome and comparison with European patients. Chin J Rheumatol 14(6):394\u2013397","journal-title":"Chin J Rheumatol"},{"issue":"11","key":"3776_CR9","first-page":"904","volume":"48","author":"N Xu","year":"2009","unstructured":"Xu N, Yao Z, Wen Z, Yan Z, Xiao-feng Z (2009) Classification and clinical analysis of 165 patients with antiphospholipid syndrome. Chin J Intern Med 48(11):904\u2013907","journal-title":"Chin J Intern Med"},{"issue":"16","key":"3776_CR10","first-page":"1367","volume":"84","author":"L Xiao-mei","year":"2004","unstructured":"Xiao-mei L, Xiao-min L, Mai-xing AI, Xiao-feng Z, Fu-lin T (2004) Clinical analysis of 61 patients with antiphospholipid syndrome. Natl Med J China 84(16):1367\u20131370","journal-title":"Natl Med J China"},{"issue":"3","key":"3776_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/MBC.0000000000000576","volume":"28","author":"AA Nageswara Rao","year":"2017","unstructured":"Nageswara Rao AA, Elwood K, Kaur D, Warad DM, Rodriguez V (2017) A retrospective review of pediatric antiphospholipid syndrome and thrombosis outcomes. Blood Coagul Fibrinolysis 28(3):205\u2013210. doi:\n10.1097\/MBC.0000000000000576","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"3776_CR12","first-page":"286","volume":"14","author":"A Zamora-Ustaran","year":"2012","unstructured":"Zamora-Ustaran A, Escarcega-Alarc\u00f3n RO, Garcia-Carrasco M, Faugier E, Mendieta-Zeron S, Mendoza-Pinto C, Montiel-Jarquin A, Mu\u00f1oz-Guarneros M, Lopez-Colombo A, Cervera R (2012) Antiphospholipid syndrome in mexican children. Isr Med Assoc J 14(5):286\u2013289","journal-title":"Isr Med Assoc J"},{"issue":"6","key":"3776_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","volume":"74","author":"R Cervera","year":"2015","unstructured":"Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ram\u00f3n E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, Tincani A, Taglietti M, Theodossiades G, Nomikou E, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de Groot PG, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Qu\u00e9r\u00e9 I, Hachulla E, Vasconcelos C, Fern\u00e1ndez-Nebro A, Haro M, Amoura Z, Miyara M, Tektonidou M, Espinosa G, Bertolaccini ML, Khamashta MA, Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies) (2015) Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 74(6):1011\u20131018. doi:\n10.1136\/annrheumdis-2013-204838","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3776_CR14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-3476(96)70064-1","volume":"129","author":"E Scheven von","year":"1996","unstructured":"von Scheven E, Athreya BH, Rose CD, Goldsmith DP, Morton L (1996) Clinical characteristics of antiphospholipid syndrome in children. J Pediatr 129(3):339\u2013345","journal-title":"J Pediatr"},{"issue":"5","key":"3776_CR15","doi-asserted-by":"publisher","first-page":"e1100","DOI":"10.1542\/peds.2008-1209","volume":"122","author":"T Avcin","year":"2008","unstructured":"Avcin T, Cimaz R, Silverman ED, Cervera R, Gattorno M, Garay S, Berkun Y, Sztajnbok FR, Silva CA, Campos LM, Saad-Magalhaes C, Rigante D, Ravelli A, Martini A, Rozman B, Meroni PL (2008) Paediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics 122(5):e1100\u2013e1107. doi:\n10.1542\/peds.2008-1209","journal-title":"Pediatrics"},{"issue":"5","key":"3776_CR16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3760\/cma.j.issn.0578-1426.2016.05.011","volume":"55","author":"JL Zhao","year":"2016","unstructured":"Zhao JL, Sun YD, Zhang Y, Xu D, Wang Q, Li MT, Zeng XF (2016) The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome. Zhonghua Nei Ke Za Zhi 55(5):386\u2013391. doi:\n10.3760\/cma.j.issn.0578-1426.2016.05.011","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"5","key":"3776_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.semnephrol.2015.08.009","volume":"135","author":"S Sciascia","year":"2015","unstructured":"Sciascia S, Baldovino S, Schreiber K, Solfietti L, Roccatello D (2015) Antiphospholipid syndrome and the kidney. Semin Nephrol 135(5):478\u2013486. doi:\n10.1016\/j.semnephrol.2015.08.009","journal-title":"Semin Nephrol"},{"issue":"2","key":"3776_CR18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar4549","volume":"16","author":"PL Meroni","year":"2014","unstructured":"Meroni PL, Chighizola CB, Rovelli F, Gerosa M (2014) Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers. Arthritis Res Ther 16(2):209","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"3776_CR19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF01957376","volume":"154","author":"GD Nucci Di","year":"1995","unstructured":"Di Nucci GD, Mariani G, Arcieri P, Cerbo R, Tarani L, Bruni L, Tozzi MC, Vignetti P (1995) Antiphospholipid syndrome in young patients. Two cases of cerebral ischemic accidents. Eur J Pediatr 154(4):334","journal-title":"Eur J Pediatr"},{"issue":"3","key":"3776_CR20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1055\/s-0028-1082271","volume":"34","author":"BJ Hunt","year":"2008","unstructured":"Hunt BJ (2008) Paediatric antiphospholipid antibodies and antiphospholipid syndrome. Semin Thromb Hemost 34(3):274\u2013281","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"3776_CR21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/art.22360","volume":"55","author":"Y Berkun","year":"2006","unstructured":"Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, Revel-Vilk S, Kenet G (2006) Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum 55(6):850\u2013855","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3776_CR22","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","volume":"101","author":"M Galli","year":"2003","unstructured":"Galli M, Luciani D, Bertolini G, Barbui T (2003) Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101(5):1827\u20131832. doi:\n10.1182\/blood-2002-02-0441","journal-title":"Blood"},{"issue":"6","key":"3776_CR23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.autrev.2013.11.004","volume":"13","author":"Q Reynaud","year":"2014","unstructured":"Reynaud Q, Lega JC, Mismetti P, Chapelle C, Wahl D, Cath\u00e9bras P, Laporte S (2014) Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev 13(6):595\u2013608. doi:\n10.1016\/j.autrev.2013.11.004","journal-title":"Autoimmun Rev"},{"issue":"2","key":"3776_CR24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/107602960401000201","volume":"10","author":"MA Ozt\u00fcrk","year":"2004","unstructured":"Ozt\u00fcrk MA, Haznedaro\u011flu IC, Turgut M, G\u00f6ker H (2004) Current debates in antiphospholipid syndrome: the acquired antibody-mediated thrombophilia. Clin Appl Thromb Hemost 10(2):89\u2013126","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"3776_CR25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2249.2004.02497.x","volume":"136","author":"CG Mackworth-Young","year":"2004","unstructured":"Mackworth-Young CG (2004) Antiphospholipid syndrome: multiple mechanisms. Clin Exp lmmunol 136(3):393\u2013401","journal-title":"Clin Exp lmmunol"},{"issue":"8","key":"3776_CR26","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","volume":"102","author":"M Galli","year":"2003","unstructured":"Galli M, Luciani D, Bertolini G, Barbui T (2003) Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102(8):2717\u20132723","journal-title":"Blood"},{"key":"3776_CR27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.thromres.2004.06.034","volume":"114","author":"G Reber","year":"2004","unstructured":"Reber G, de Moerloose P (2004) Anti-beta2-glycoprotein I antibodies \u2013when and how should they be measured? Thromb Res 114:527\u2013531","journal-title":"Thromb Res"},{"issue":"9","key":"3776_CR28","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.autrev.2014.05.001","volume":"13","author":"ML Bertolaccini","year":"2014","unstructured":"Bertolaccini ML, Amengual O, Andreoli L, Atsumi T, Chighizola CB, Forastiero R, de Groot P, Lakos G, Lambert M, Meroni P, Ortel TL, Petri M, Rahman A, Roubey R, Sciascia S, Snyder M, Tebo AE, Tincani A, Willis R (2014) 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev 13(9):917\u2013930. doi:\n10.1016\/j.autrev.2014.05.001","journal-title":"Autoimmun Rev"},{"key":"3776_CR29","doi-asserted-by":"publisher","unstructured":"Chighizola CB, Andreoli L, de Jesus GR, Banzato A, Pons-Estel GJ, Erkan D; APS ACTION (2015) The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Lupus 24(9): 980\u2013984. doi: \n10.1177\/0961203315572714","DOI":"10.1177\/0961203315572714"},{"issue":"2","key":"3776_CR30","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/art.33340","volume":"64","author":"K Otomo","year":"2012","unstructured":"Otomo K, Atsumi T, Amengual O, Fujieda Y, Kato M, Oku K, Horita T, Yasuda S, Koike T (2012) Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Arthritis Rheum 64(2):504\u2013512. doi:\n10.1002\/art.33340","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3776_CR31","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.autrev.2012.11.008","volume":"12","author":"V Pengo","year":"2013","unstructured":"Pengo V, Banzato A, Denas G, Jose SP, Bison E, Hoxha A, Ruffatti A (2013) Correct laboratory approach to APS diagnosis and monitoring. Autoimmun Rev 12(8):832\u2013834. doi:\n10.1016\/j.autrev.2012.11.008","journal-title":"Autoimmun Rev"},{"issue":"6","key":"3776_CR32","doi-asserted-by":"publisher","first-page":"e0158076","DOI":"10.1371\/journal","volume":"11","author":"I Parodis","year":"2016","unstructured":"Parodis I, Arnaud L, Gerhardsson J, Zickert A, Sundelin B, Malmstr\u00f6m V, Svenungsson E, Gunnarsson I (2016) Antiphospholipid antibodies in lupus nephritis. PLoS ONE 11(6):e0158076. doi:\n10.1371\/journal","journal-title":"PLoS ONE"},{"issue":"3","key":"3776_CR33","doi-asserted-by":"publisher","first-page":"R93","DOI":"10.1186\/ar2736","volume":"11","author":"H Zheng","year":"2009","unstructured":"Zheng H, Chen Y, Ao W, Shen Y, Chen X-w, Dai M, Wang X-d, Yan Y-c, Yang C-d (2009) Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases. Arthritis Res Ther 11(3):R93. doi:\n10.1186\/ar2736","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3776_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/0961203312460722","volume":"22","author":"C Gardiner","year":"2013","unstructured":"Gardiner C, Hills J, Machin SJ, Cohen H (2013) Diagnosis of antiphospholipid syndrome in routine clinical practice. Lupus 22(1):18\u201325. doi:\n10.1177\/0961203312460722","journal-title":"Lupus"},{"issue":"2","key":"3776_CR35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000080658","volume":"135","author":"G Obermoser","year":"2004","unstructured":"Obermoser G, Bitterlich W, Kunz F, Sepp NT (2004) Clinical significance of anticardiolipin and anti-beta2-glycoprotein I antibodies. Int Arch Allergy Immunol 135(2):148\u2013153","journal-title":"Int Arch Allergy Immunol"},{"issue":"11","key":"3776_CR36","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1191\/0961203303lu471oa","volume":"12","author":"LM Campos","year":"2003","unstructured":"Campos LM, Kiss MH, D\u2019Amico EA, Silva CA (2003) Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Lupus 12(11):820\u2013826","journal-title":"Lupus"},{"issue":"18","key":"3776_CR37","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.1997.00440390101013","volume":"157","author":"S Krnic-Barrie","year":"1997","unstructured":"Krnic-Barrie S, O\u2019Connor CR, Looney SW, Pierangeli SS, Harris EN (1997) A retrospective review of 61 patients with antiphospholipid syndrome: analysis of factors influencing recurrent thrombosis. Arch Intern Med 157(18):2101\u20132108","journal-title":"Arch Intern Med"},{"issue":"7","key":"3776_CR38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1191\/0961203303lu447ed","volume":"12","author":"MA Khamashta","year":"2003","unstructured":"Khamashta MA, Shoenfeld Y (2003) Antiphospholipid syndrome: a consensus for treatment? Lupus 12(7):495","journal-title":"Lupus"},{"issue":"17","key":"3776_CR39","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","volume":"118","author":"V Pengo","year":"2011","unstructured":"Pengo V, Ruffatti A, Legnani C, Testa S, Fierro T, Marongiu F, De Micheli V, Gresele P, Tonello M, Ghirarduzzi A, Bison E, Denas G, Banzato A, Padayattil Jose S, Iliceto S (2011) Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood 118(17):4714\u20134718","journal-title":"Blood"},{"issue":"9","key":"3776_CR40","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","volume":"50","author":"A Ruffatti","year":"2011","unstructured":"Ruffatti A, Tonello M, Visentin MS, Bontadi A, Hoxha A, De Carolis S, Botta A, Salvi S, Nuzzo M, Rovere-Querini P, Canti V, Mosca M, Mitic G, Bertero MT, Pengo V, Boffa MC, Tincani A (2011) Risk factors for pregnancy failure in patients with antiphospholipid syndrome treated with conventional therapies: a multicentre case\u2013control study. Rheumatology (Oxford) 50(9):1684\u20131689. doi:\n10.1093\/rheumatology\/ker139","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3776-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3776-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3776-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T10:04:53Z","timestamp":1524477893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3776-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,26]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["3776"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3776-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,26]]}}}